Sep 30, 2019
Emily Evans is the Managing Director of Health Policy for Hedgeye Potomac Research, serving as a “translator and tour guide” for investors seeking to read the tea leaves coming out of Washington, DC. She previously spent 20 years financing health care facilities in the tax-exempt sector for J.C. Bradford and Avondale Partners. In our discussion, we delve into the health care pricing policies coming out of the current administration in Washington.
Visit A Second Opinion's website here: